Site Search
Professionals 15 results
Capabilities 4 results
Practice Area
Our Patent Litigation Practice is one of the country’s most active and highly regarded. Our seasoned patent litigators bring extensive courtroom experience
to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances
and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022).
to every matter we handle. According to Lex Machina, we are among the top three national patent defense firms in the country for number of appearances
and cases filed, and we also were the top national defense firm for number of patent trials in the last five years (2018–2022).
Industry
Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies
involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have
technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a uniq...Read more
involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have
technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a uniq...Read more
Industry
The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic
fluctuations. To pave the way for a more accessible and innovative health care landscape—including advances in wearables, implants, diagnostics, mobility,
drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable ...Read more
fluctuations. To pave the way for a more accessible and innovative health care landscape—including advances in wearables, implants, diagnostics, mobility,
drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable ...Read more
Insights & News 19 results
Speaking Engagement
|March 6, 2025
Ivan Poullaos Speaks on ANDA Litigation Strategies at 9th International IP Skills Summit
Winston & Strawn partner Ivan Poullaos was a featured speaker at the 9th International IP Skills Summit (IIPSS) in Hyderabad, India. Winston sponsored the
invite-only summit, which focused on Paragraph IV and biosimilar patent litigation and was attended by over 300 participants from around the world,
including pharmaceutical IP attorneys and in-house counsel.
invite-only summit, which focused on Paragraph IV and biosimilar patent litigation and was attended by over 300 participants from around the world,
including pharmaceutical IP attorneys and in-house counsel.
Recognitions
|October 2, 2024
|1 Min Read
Chuck Klein and Jovial Wong Named Among Top Attorneys in ANDA Litigation for 2024
Winston & Strawn partners Chuck Klein and Jovial Wong were recognized in Patexia’s report “Top Attorneys in ANDA Litigation: A Spotlight on the Best
Performers and Most Active of 2024.”
Performers and Most Active of 2024.”
Speaking Engagement
|April 25, 2024
Ivan Poullaos Discusses Jury Trial Preparedness in ANDA Cases at Paragraph IV Disputes Conference
Winston & Strawn partner Ivan Poullaos spoke at the 20th Annual Paragraph IV Disputes Conference, April 25-26, 2024, in New York City.
Other Results 8 results
Law Glossary
What Is the Standard for the FDA to Grant a Generic Drug License?
An Abbreviated New Drug Application (ANDA) must contain evidence that the proposed generic drug product is bioequivalent to the reference drug.
Law Glossary
What Are the Patent Litigation Differences Between the BPCIA and Hatch-Waxman Act?
There are fundamental differences between the abbreviated approval processes to obtain FDA approval for biosimilars and generic drugs as those processes
relate to patent litigation.
relate to patent litigation.
Location
Launched in 2013, Winston & Strawn’s Silicon Valley office is home to nationally recognized attorneys that draw clients from Fortune 500 companies, startups,
and everything in between. Led by Kelly Hunsaker—who has deep roots in Silicon Valley spanning nearly three decades—the office draws from the firm’s
deep bench strength and global network of resources to serve clients in a variety of industries, including the semiconductor, computer hardware...Read more
and everything in between. Led by Kelly Hunsaker—who has deep roots in Silicon Valley spanning nearly three decades—the office draws from the firm’s
deep bench strength and global network of resources to serve clients in a variety of industries, including the semiconductor, computer hardware...Read more